Background: Human papillomavirus (HPV) vaccination is below national goals in the United States. Health care providers are at the forefront of improving vaccination in the United States, given their close interactions with patients and parents.
Introduction
In 2013, the US President's Cancer Panel identified provider recommendations as one of three priorities for improving the rates of human papillomavirus (HPV) vaccination [1] . A strong provider recommendation of the HPV vaccine reflects up to a 5-fold increase in the decision by parents to vaccinate their child [2] . Multiple national organizations have echoed their support for providers to deliver strong recommendations for the HPV vaccine to eligible adolescents, including the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American College of Physicians, the Centers for Disease Control and Prevention (CDC), and the Immunization Action Coalition [3] . Research on strategies to improve the consistency and quality of provider recommendations is pivotal to achieving the Healthy People 2020 goal of 80% HPV vaccination coverage set by the CDC [4] .
Knowledge about HPV vaccines influences the providers' intention to recommend HPV vaccination to their patients [5] [6] [7] . Low knowledge of the benefits of HPV vaccination among providers may contribute to low HPV vaccination rates in regions such as the Intermountain West, inclusive of Utah, Idaho, Nevada, Wyoming, Colorado, Montana, Arizona, and New Mexico [8] . In 2015, Utah was ranked the 49th state for HPV vaccine initiation among females (47.8%) and among the lowest for males (40.9%) aged 13 to 17 years [9] . Although knowledge deficits about HPV vaccines and HPV vaccine guidelines among the providers in Utah have not been described, previous research indicates that there is a high prevalence of missed opportunities for HPV vaccination in Utah [10] . Missed opportunities may reflect providers' misconceptions or lack of knowledge about HPV vaccination. In addition, contextual factors such as cultural or religious assumptions regarding adolescents' sexual practices may influence providers' perceptions of HPV and their subsequent recommendation of the vaccine to their patients [11, 12] . Thus, improving provider recommendations of the HPV vaccine to their patients first requires assessments of providers' knowledge about HPV vaccines and HPV vaccine guidelines.
Theoretically informed approaches to improving HPV vaccination are necessary to advance research and practice in this area. The social ecological framework (SEF) is a health promotion model that encompasses multiple levels of influence. In the SEF, individual, interpersonal, and organizational characteristics constitute three of the five levels of influence on a public health intervention. Multilevel targeted interventions promote healthy practices such as the administration of HPV vaccines to prevent HPV-related morbidity and mortality [13] . For example, individual, interpersonal, and organizational SEF levels are represented in this study as parent and patient, health care provider, and organizational characteristics, respectively. By examining these characteristics from the health care providers' perspectives, the SEF provides the theoretical foundation for understanding how these characteristics influence providers' readiness to deliver a strong recommendation for HPV vaccination to patients and parents.
Moreover, the exposure of health care providers to the health care system, parents, and patients gives them unique perspectives on the clinical barriers and strategies for improving HPV vaccination. In this mixed-methods study, we describe providers' knowledge of HPV vaccines and HPV vaccine guidelines and their perceptions of barriers to and strategies for improving HPV vaccination in Utah, which is a state with low HPV vaccination rates. We aimed to assess associations of demographic and practice characteristics with providers' knowledge of HPV vaccination and HPV vaccination guidelines to identify provider groups with knowledge deficits. Providers' perceptions of the barriers to and strategies for improving HPV vaccination were described to contextualize the results.
Methods
Mixed-method approaches that combine qualitative and quantitative data resources provide a more complete description of a phenomenon than a single methodological approach alone [14, 15] . Using a Web-based survey, our goal was to identify demographic and practice characteristics that are associated with providers' knowledge about HPV vaccination and HPV vaccination guidelines in a state with a low HPV vaccination rate. Qualitative open-ended survey questions were used to further contextualize the findings from the survey analysis by describing providers' perceptions of barriers to and strategies for improving HPV vaccination. The usability and technical functionality of the survey were assessed during pilot testing before data collection occurred. This study was deemed exempt research by the institutional review board of the University of Utah.
Participants and Data Collection
During three periods from 2014-2015, a self-administered closed survey was distributed via email listservs to 3 statewide provider organizations, with sample sizes of approximately 600, 740, and 330 for pediatrics, family medicine, and nursing, respectively. The survey comprised 58 items, with 1 to 4 questions per page. Participants received notification of a forthcoming opportunity to participate in a research study, with the option to opt out from further contact (n=1). Eligible participants who did not opt out received an additional email invitation to complete the Web-based survey within 2 weeks. Two biweekly reminder emails were then sent within 4 weeks after the initial email. Anonymous submission of the completed survey constituted consent. Participants had the option to receive a US $20 Amazon gift card or make a US $20 donation to a local children's hospital. The approximate response rates were as follows: pediatrics 18.0% (108/600), family practice 21.8% (161/740), and nurse practitioners 39.1% (129/330). Of these, 65 participants were excluded because they were not a pediatrician, family medicine physician, or nurse practitioner (eg, office staff and medical assistant), and 79 participants were excluded because they did not see patients in a clinical setting. The final sample of 254 participants who were analyzed comprised 75 pediatricians, 136 family medicine physicians, and 43 nurse practitioners.
Independent Variables
Demographics included age, sex, race, marital status, and religion. Practice characteristics included practice location, Vaccines for Children (VFC) provider status, specialty type, practice type, practice size, number of patients per day, number of patients per week, most common form of patient payment, and provider-reported majority Hispanic population. Variable selection was guided by the SEF and included factors that represented multiple levels of influence, including individual, interpersonal, and community (eg, parents, patients, health care providers, organizations, and public policy). Variable selection was also based on extant literature and our previous research in Utah related to HPV vaccination.
Outcome Measures
On the basis of a review of the literature, two HPV knowledge measures were measured (see Table 1 ): knowledge of HPV vaccination and knowledge of HPV vaccination guidelines. Knowledge of HPV vaccination was measured for each participant based on their responses to 12 true or false questions resulting in a score ranging between 0 and 12. This cutoff selection was based on the distribution of the data along a natural median divide. For analysis, HPV vaccination knowledge scores summarized into a binary variable with ≤10 indicating low knowledge and 11 to 12 indicating high knowledge.
The second outcome, knowledge of HPV vaccination guidelines, was measured for each respondent based on 3 questions about the timing and age of HPV vaccination. For analysis, we aggregated responses into a binary variable, with those who incorrectly answered any of the 3 questions as lower knowledge and those who answered all 3 questions correctly as high knowledge.
Statistical Analysis
Summary statistics were reported for demographic and practice characteristics. Statistics were calculated for nonmissing data as indicated in Tables 2-5 . Chi-square and Fisher exact tests were used for examining associations in univariate analyses with Stata version 14.1 (StatCorp LP). All P values were two-sided and considered significant at P=.05.
Qualitative Data and Analyses
Qualitative data were extracted from 4 open-ended questions of the Web-based survey to describe providers' perceptions of barriers to and strategies for improving HPV vaccination among males and females to "ground" the quantitative results. Grounding is a mixed-methods technique for combining qualitative and quantitative data to contextualize a phenomenon [14, 15] . Responses were read and reread by 2 authors to familiarize with the data and identify themes. A deductive coding structure was created using levels of the SEF and revised as coding developed. Themes pertaining to providers' perceptions at interpersonal (parents, patients, and providers) and organizational (health care system or public policy) levels of the SEF are described herein. Pertinent differences in providers' perceptions about HPV vaccination for girls and boys are described. 
Results

Demographic and Practice Characteristics Associated With HPV Vaccination Knowledge and Guidelines
Participants included 136 family practice physicians, 75 pediatricians, and 43 nurse practitioners. No demographic factors were associated with providers' knowledge of HPV vaccination (see Table 2 ).
In Table 3 , specialty was associated with knowledge; family practice physicians had the highest proportion of providers with The following results describe health care providers' perceptions of barriers to HPV vaccination and strategies for improving HPV vaccination with accompanying illustrative quotes presented in the text and in Table 6 . Each section is separated by (1) individual, (2) interpersonal, and (3) organizational constructs of the SEF, including (1) parents and patients, (2) health care providers, and (3) 
Providers' Perceptions of HPV Vaccination Barriers
Barriers Related to Parents and Patients
In the open-ended questions, providers described concerns about sexual activity and promiscuity (n=69), vaccine refusal or reluctance (n=62), inadequate or incorrect parental knowledge (n=96), and low perceived risk of HPV (n=67) as the most common barriers to vaccination for parents and patients (see Table 6 ). To providers, parents' perceptions about their child's sexual activity influenced their decisions about HPV vaccination. One provider observed:
I do see a lot of moms "explain" the vaccine to their children saying, "It would be a good idea in case you were raped" rather than in case you had a sexual partner with HPV.
Providers responded that parents believed that the HPV vaccine increases sexual promiscuity, is unnecessary because their child is not sexually active, and that their child is not at risk for HPV infection. Providers connected parents' concerns about sexuality with perceived risk of HPV infection. For example, one provider stated:
...if they've remained virginal, they assume the partner they marry is virginal and thus they aren't at risk [for HPV]. Not thinking their partner might not be truthful OR that this marriage might not last and they could be exposed when they remarry, which by then [they] could be past immunization age.
Providers listed inadequate or incorrect parental knowledge as a barrier to vaccination about the purpose of HPV vaccination (Table 6 ). Providers felt that parental "misconceptions" were the result of parents being "very misinformed by relatives, or friends." For example, a common endorsed barrier to vaccinating boys was the perception that HPV vaccines only prevent cervical cancer.
Barriers Related to Health Care Providers
Only a few respondents identified providers' barriers to HPV vaccination. However, there were some concerns such as vaccination not being a priority (n=19). One provider stated:
We occasionally forget the vaccine at sick visits.
Some providers were openly unsupportive of HPV vaccination (n=16). One provider stated:
Without a history of homosexuality, I do not see a great advantage to the immunization of boys.
Whereas some providers felt HPV vaccines were not cost-effective, others expressed skepticism, stating they wanted "more science showing benefit in men" (n=13). A provider downplayed the need for HPV vaccination by stating:
Issues of sexually transmitted disease do not seem to be an issue in my clinical setting.
Barriers Related to Organizations
Organizational barriers to HPV vaccination included cost (n=32), completing follow-up doses (n=22), and infrequency of vaccinating at regular well-child or primary care visits (n=16).
Perceptions of HPV Vaccination Improvement Strategies
HPV Vaccination Improvement Strategies for Parents and Patients
Parental education was the most common strategy for improving HPV vaccination (n=81). Providers felt that education should focus on reducing negative sexual connotations about the HPV vaccine. One provider relayed:
Basically, debunking the myth that it leads to more sex.
Providers felt that parents could be educated directly during clinic visits and through broader community health promotion campaigns. Informing parents about the prevalence of HPV within their community was suggested. One provider stated:
Better understanding that it is a ubiquitous virus and infects nearly everyone in the world, regardless of sexual partner number.
In some instances, providers' perceptions varied by gender, with different ideas for vaccinating girls and boys (n=23, Table  6 ). Providers felt that parents need information about the efficacy of the HPV vaccine for reducing HPV-related morbidity among males.
HPV Vaccination Improvement Strategies for Providers
The most common suggestion for improving HPV vaccination by the providers was to tailor recommendations (n=23) and to focus on preventing cancer rather than sexually transmitted infections (n=18). Providers also felt that routine HPV vaccination would reduce parental and patient hesitancy (n=17, Table 6 ). Providers indicated that vaccine hesitancy was related to low perceived risk among parents and patients. Therefore, providers emphasized the importance of framing HPV vaccination recommendations:
...discussing the fact that [patients] can be exposed from a future husband who did not know he was infected.
Another provider echoed this perception:
Emphasizing that nonsexual intercourse exposure results in HPV acquisition and that there are respiratory and oral cancers associated too. Cancer prevention focus (n=18) Providers "To make it more routine like it is expected to get it in medical culture rather than this optional/additional vaccine." Make HPV vaccination routine practice (n=17) "Discussing the fact that [patients] can be exposed from a future husband who did not know he was infected." Tailored recommendation (n=23) "I need some information sheets, reassurance sheets, on side effects and safety, which are easy to hand out." Providers endorsed the need for better educational information to be displayed in health clinics and comprehensible educational information on HPV vaccination to share with parents (n=22, Table 6 ).
HPV Vaccination Improvement Strategies for Organizations and Policy
Providers expressed support for public policy requiring HPV vaccination for school enrollment (n=22, Table 6 ). One provider also felt that standing orders for HPV vaccination would improve consistency in HPV vaccination.
Discussion
Principal Findings
This study is the first to describe providers' knowledge of HPV vaccination and HPV vaccination guidelines, with added context of providers' perceptions related to the barriers to and facilitators of HPV vaccination. Despite Utah's very low HPV vaccination prevalence, another study with providers in Utah using similar survey items to assess providers' knowledge of HPV indicated a substantially lower proportion of providers with correct knowledge compared with our sample (mean proportion of correct responses=57.7% vs 79.4%; [16] ). Yet provider endorsement of HPV vaccination varies. There are some significant correlates of lower vaccination knowledge with provider demographics, which are described hereafter to inform future efforts targeted toward providers' recommendation of HPV vaccination In addition, our qualitative results provide essential context for improving provider recommendations in states with low HPV vaccination. This study makes an important contribution to existing literature by using a mixed-methods design to describe providers' perceptions of vaccine barriers that suppress HPV vaccination in a state with low HPV vaccine receipt.
Examination of multiple levels of the SEF is integral to designing effective HPV vaccination interventions. On an individual and interpersonal level, health care practice characteristics that were associated with lower knowledge of HPV vaccination and guidelines among providers in Utah include provider specialty (eg, pediatricians and nurse practitioners), practice type (eg, private practice and hospitals or urgent care clinics), and number of patients seen per day (eg, <15 and ≥30 patients per day). Additionally, younger providers (aged 30-39 years) and older providers (aged ≥50 years) had lower knowledge compared with those who were middle aged Providers who saw adolescent patients but did not routinely provide vaccinations, as well as those who were not VFC providers had lower knowledge about HPV vaccination and guidelines than did VFC providers. One explanation for this finding may be that VFC providers are potentially more accustomed to routinely providing HPV vaccines and thus may be more knowledgeable about this vaccine. In addition, the differential distribution of clinicians by specialty, with more family medicine providers than physicians practicing in rural areas [17] , may have influenced our results on providers' knowledge of HPV vaccination and guidelines. Although we did not examine the influence of rurality in this study, prior research has documented deficits in patient-provider communication about HPV vaccines from parents in rural areas as compared with those in urban areas [18] .
Despite finding several associations between provider demographics and knowledge, the most compelling finding from this study was from our qualitative analyses demonstrating providers' overwhelming perception of an immediate need for improved parental education regarding HPV vaccines. Misinformation among parents was portrayed by providers as the strongest and most consistent barrier to vaccination. Providers described how parental beliefs regarding sexuality and HPV vaccination impede HPV vaccination and make it difficult to deliver a strong recommendation in support of HPV vaccination. Providers expressed frustration at not having access to educational materials that they need to accurately and efficiently communicate with parents and patients about HPV vaccination. However, improvements in parental knowledge alone may not eliminate hesitancy toward HPV vaccination [19] . Continued promotion of HPV vaccination on an individual, interpersonal, organizational, and community level is needed to support providers' strong recommendations for HPV vaccination to 11-to 12-year-old adolescents in Utah. Providers also endorsed public health campaigns as a strategy to inform parents of the ubiquity of HPV infection in their community by relaying local data on HPV prevalence for both males and females. In addition, providers supported framing the HPV vaccine as a cancer prevention mechanism for males and females. Lastly, providers felt that state policies requiring HPV vaccination would be the most powerful way to improve HPV vaccination. The feasibility of these strategies should be further explored.
Although health care providers' hesitancy was not explicitly noted as a barrier to HPV vaccination, our qualitative analysis revealed that some providers have persistent negative perceptions of HPV vaccination. This reticence to endorse HPV vaccination has not only been observed in Utah but has also been described in national surveys [20] . Whereas parents report variation in the quality of provider recommendations, those who receive a strong endorsement for HPV vaccination are much more likely to choose vaccination [21] . Providers' hesitancy to discuss sexual health, lack of time to address parental concerns about vaccine efficacy and safety, and perceptions of low self-efficacy to guide parents' decisions about vaccination may discourage strong recommendations for HPV vaccination [12, 22, 23] . Furthermore, the lack of parental knowledge about HPV vaccination, which is noted as a barrier by providers, may be an unintended consequence of providers' low knowledge about HPV vaccination and guidelines, potentially creating a situation in which providers with lower knowledge avoid discussing the HPV vaccine with their patients. Given the powerful impact of the strength and quality of providers' HPV vaccine recommendations on parents' decisions to vaccinate [21] , providers in these settings may indeed benefit from education on the costs and benefits of HPV vaccination and the consequences of an unvaccinated population. Future research is warranted that explores the association between providers' knowledge about HPV vaccination as well as guidelines and the administration of the HPV vaccine. 
Conclusions
Utah's vaccination rates are among the lowest in the United States. Theoretically informed interventions to improve vaccination through provider recommendations need to fully appreciate the public health benefit of HPV vaccination. This study provides evidence that provider-based HPV vaccine interventions must extend beyond improving providers' knowledge about vaccination. Our analysis revealed that providers have knowledge of HPV vaccination and guidelines, but contextual factors accentuate the need for supporting providers in administering strong, consistent, and high-quality recommendations for the HPV vaccine in Utah. Recognizing the importance of provider's experiences, we summarized their suggestions for improving HPV vaccination and recommend that providers' perspectives be considered in the development of future interventions. Specifically, providers consider parental misconceptions to be the strongest barrier to HPV vaccination in Utah. Yet, they believe that misinformation can be corrected through direct parental education and broad public health campaigns. Providers' recognize the value parents place on the dissemination of accurate information through clinical settings and appreciate the importance of a strong provider recommendation. In summary, providers in Utah have high knowledge about HPV vaccination, but they need support in correcting misinformation that persists at multiple levels of the SEF, including among patients, parents, colleagues, and communities.
